MX2019005828A - Tableta que comprende aglutinante y eritritol separados. - Google Patents

Tableta que comprende aglutinante y eritritol separados.

Info

Publication number
MX2019005828A
MX2019005828A MX2019005828A MX2019005828A MX2019005828A MX 2019005828 A MX2019005828 A MX 2019005828A MX 2019005828 A MX2019005828 A MX 2019005828A MX 2019005828 A MX2019005828 A MX 2019005828A MX 2019005828 A MX2019005828 A MX 2019005828A
Authority
MX
Mexico
Prior art keywords
delivery vehicle
vehicle tablet
tablet
erythritol
weight
Prior art date
Application number
MX2019005828A
Other languages
English (en)
Inventor
Wittorff Helle
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/356,175 external-priority patent/US10543205B2/en
Priority claimed from PCT/DK2016/050377 external-priority patent/WO2018091048A1/en
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Publication of MX2019005828A publication Critical patent/MX2019005828A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se refiere a una tableta de vehículo de suministro oral, la tableta de vehículo de suministro siendo formada por la compresión de una pluralidad de partículas, en donde la tableta de vehículo de suministro oral comprende alcohol de azúcar o alcoholes de azúcar en una cantidad de 40 a 99.9% en peso de la tableta de vehículo de suministro, en donde la tableta de vehículo de suministro oral comprende partículas de eritritol no directamente compresibles (no DC) en una cantidad de 15 a 50% en peso de la tableta de vehículo de suministro, en donde la tableta de vehículo de suministro oral comprende uno o más aglutinantes distintos de aglutinantes granulados para el alcohol o los alcoholes de azúcar en una cantidad de 0.1 a 6% en peso de la tableta, en donde la tableta de vehículo de suministro comprende una pluralidad de otras partículas de alcohol de azúcar en una cantidad de por lo menos 10% en peso de la tableta de vehículo de suministro, y en donde dichas otras partículas de alcohol de azúcar tienen una composición que es diferente de dicho eritritol no DC.
MX2019005828A 2016-11-18 2017-10-13 Tableta que comprende aglutinante y eritritol separados. MX2019005828A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/356,175 US10543205B2 (en) 2016-11-18 2016-11-18 Oral delivery vehicle containing nicotine
PCT/DK2016/050377 WO2018091048A1 (en) 2016-11-18 2016-11-18 Oral delivery vehicle
PCT/DK2017/050342 WO2018091050A1 (en) 2016-11-18 2017-10-13 Tablet comprising separate binder and erythritol

Publications (1)

Publication Number Publication Date
MX2019005828A true MX2019005828A (es) 2019-07-08

Family

ID=60083055

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019005928A MX2019005928A (es) 2016-11-18 2017-10-13 Método para proporcionar beneficios para el cuidado bucal.
MX2019005828A MX2019005828A (es) 2016-11-18 2017-10-13 Tableta que comprende aglutinante y eritritol separados.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019005928A MX2019005928A (es) 2016-11-18 2017-10-13 Método para proporcionar beneficios para el cuidado bucal.

Country Status (14)

Country Link
EP (2) EP3541360A1 (es)
JP (2) JP6840849B2 (es)
KR (1) KR102582802B1 (es)
CN (2) CN109952092B (es)
AU (4) AU2017360584B2 (es)
BR (2) BR112019008138A2 (es)
CA (2) CA3040830C (es)
DK (1) DK3541359T3 (es)
ES (1) ES2860802T3 (es)
MA (1) MA46822A (es)
MX (2) MX2019005928A (es)
PL (1) PL3541359T3 (es)
RU (1) RU2736072C1 (es)
WO (2) WO2018093501A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11096895B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11058641B2 (en) * 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11096896B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096894B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
ES2951848T3 (es) * 2018-05-17 2023-10-25 Fertin Pharma As Un chicle en comprimidos adecuado para principios farmacéuticos activos ingredientes
US11135157B2 (en) * 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US20190350858A1 (en) * 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US20210106516A1 (en) * 2019-10-11 2021-04-15 Fertin Pharma A/S Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
KR102345862B1 (ko) * 2021-03-18 2022-01-03 김현진 팝핑 성분을 포함하는 고체 구강청결용 조성물

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
TW469135B (en) * 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
DK0922464T3 (da) * 1996-07-12 2005-06-06 Daiichi Seiyaku Co Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme
GB9716432D0 (en) * 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US6746697B2 (en) * 2000-12-15 2004-06-08 Phytos, Inc. Composition containing Heliopsis longipes root extract and oral carrier
JPWO2002069934A1 (ja) * 2001-03-06 2004-07-02 協和醗酵工業株式会社 口腔内速崩壊性製剤
JP2003125706A (ja) * 2001-10-23 2003-05-07 Lion Corp 口中清涼製剤
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
BRPI0514879A (pt) 2004-09-02 2008-06-24 Procter & Gamble composição para tratamento bucal compreendendo óleos essenciais
WO2006112961A2 (en) 2005-03-03 2006-10-26 Takasago International Corp. (Usa) Synergistic salivation components
JP2006335686A (ja) * 2005-06-02 2006-12-14 Hamari Chemicals Ltd 直打用エリスリトール・ソルビトール混合顆粒の製造方法
CN1709229A (zh) * 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
CN100446759C (zh) * 2006-10-16 2008-12-31 北京科信必成医药科技发展有限公司 一种天麻素口腔崩解片及其制备方法
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
WO2009007768A1 (en) * 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
EP2264042B1 (en) * 2007-07-27 2012-07-18 Cargill, Incorporated Micronization of polyols
BRPI0919183B8 (pt) * 2008-09-04 2021-05-25 Cargill Inc composição comprimível de eritritol, processo e uso do mesmo
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
WO2013125350A1 (ja) * 2012-02-23 2013-08-29 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
JP6266891B2 (ja) * 2013-03-29 2018-01-24 株式会社ロッテ 口腔内洗浄用組成物
US10357054B2 (en) * 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
EP3131639B1 (en) * 2014-04-17 2018-09-26 Unilever PLC Solid oral care compositions comprising calcium carbonate and polyethylene oxide
US10463620B2 (en) * 2014-10-16 2019-11-05 Cargill, Incorporated Process for preparing a directly compressible erythritol and uses thereof
RU2020125263A (ru) 2014-11-11 2020-08-10 Джонсон энд Джонсон Консьюмер Инк. Производные аминокислот и их использование
CN104546807B (zh) * 2015-01-21 2020-09-01 齐鲁制药有限公司 奥氮平口腔速溶膜剂

Also Published As

Publication number Publication date
KR102582802B1 (ko) 2023-10-06
AU2017360584B2 (en) 2020-12-17
CA3040830A1 (en) 2018-05-24
RU2736072C1 (ru) 2020-11-11
BR112019010115A8 (pt) 2022-07-26
MA46822A (fr) 2019-09-25
JP7297666B2 (ja) 2023-06-26
CA3044382A1 (en) 2018-05-24
AU2021200826A1 (en) 2021-03-04
KR20190086512A (ko) 2019-07-22
AU2017360378A1 (en) 2019-06-06
CN109952092A (zh) 2019-06-28
CA3040830C (en) 2021-06-15
ES2860802T3 (es) 2021-10-05
JP6840849B2 (ja) 2021-03-10
PL3541359T3 (pl) 2021-05-31
RU2019118433A3 (es) 2020-12-18
WO2018091050A1 (en) 2018-05-24
CN110087634A (zh) 2019-08-02
AU2017360584A1 (en) 2019-05-02
AU2021200826B2 (en) 2022-02-17
AU2023214357A1 (en) 2023-08-31
EP3541359B1 (en) 2021-01-27
BR112019008138A2 (pt) 2019-07-02
JP2019535732A (ja) 2019-12-12
RU2019118433A (ru) 2020-12-18
JP2019535729A (ja) 2019-12-12
WO2018093501A1 (en) 2018-05-24
CN109952092B (zh) 2022-08-23
EP3541359A1 (en) 2019-09-25
DK3541359T3 (da) 2021-02-22
EP3541360A1 (en) 2019-09-25
MX2019005928A (es) 2019-11-12
BR112019010115A2 (pt) 2019-08-20

Similar Documents

Publication Publication Date Title
MX2019005828A (es) Tableta que comprende aglutinante y eritritol separados.
MX2019005827A (es) Vehiculo de suministro oral.
PH12016502131A1 (en) Fiber board product comprising a calcium carbonate-containing material
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
PH12016501307B1 (en) Compounds
MX347753B (es) Formulaciones resistentes al abuso.
SG195082A1 (en) Anti-kir antibodies for the treatment of inflammatory disorders
MX2011003846A (es) Inmunonanoterapeuticos de nicotina.
MX2012015116A (es) Filtro para un articulo para fumar.
MX2019001121A (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion.
MY185500A (en) Macrocylic pyridine derivatives
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
WO2015025221A3 (en) System and method for capturing and using move data
MX2019008506A (es) Suplemento de alimento granulado y metodos para elaboracion y uso.
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
EP4289423A3 (en) An oral cannabinoid tablet
WO2018126262A3 (en) Smokeless products containing non-tobacco plant materials
BR112017000772A2 (pt) composição para formar um briquete de carepa de laminação, e briquete de carepa de laminação
MX2017000770A (es) Cocatalizadores para aglutinantes de caja fria de poliuretano.
MY188694A (en) Anticariogenic agent and anticariogenic composition
MX2021007427A (es) Composicion de isocianato y sistema de aglutinante conteniendo esta composicion de isocianato.
EP3793965A4 (en) COMPOSITIONS, SYSTEMS AND METHODS FOR DELIVERING AN ELEMENT IN RESPONSE TO BIOLOGICAL DEMAND
WO2018236876A3 (en) NANOEMULSIONS AND METHODS OF USE THEREOF
TH1901003452A (th) เม็ดองค์ประกอบโคโพลีเมอร์เอทธิลีน-ไวนิลแอลกอฮอล์และวิธีการผลิตสำหรับเม็ดองค์ประกอบโคโพลีเมอร์เอทิลีน-ไวนิลแอลกอฮอล์
Duckenfield 26 June 1940: Bank of England Memorandum, giving Estimates of the Amount of Gold from Occupied Countries that may have fallen into German Hands